Skip Navigation

Internal Medicine

Evaluation of Exenatide ER (Bydureon) on the duration of diabetic remisison in cats

TitleEvaluation of Exenatide ER (Bydureon) on the duration of diabetic remisison in cats
Contact Person Audrey Cook, Dip ACVIM (Internal Medicine); Dip ABVP (Feline Practice)
Hospital Phone: 979-845-2351
Email: akcook@cvm.tamu.edu
Species Cats
Inclusion Criteria and General Background Information

Cats with a recent history (4-12 weeks) of diabetic remission.

Remission is defined as a blood glucose <200 mg/dl for >2 weeks without insulin administration.

Exclusion Criteria Cats with severe concurrent disease(s) are not eligible for this trial.
Owner Commitments

Cats will be examined at the hospital once a month and given either Exenatide ER or placebo by subcutaneous injection. Trial duration is 12 months or the recurrence of diabetes mellitus (which ever is sooner).

Financial Incentives

There is no cost for participation in this trial.

Cats will receive a full evaluation at the time of enrollment, which will include blood and urine testing. Expenses associated with every examination and all diagnostic testing will be covered by the trial. There is no costs associated with administration of Exenatide or placebo.

There are no financial benefits for participation in this trial.

This trial is currently open!

Study Information

Investigation of a novel treatment (urethral thermoplasty) for urinary incontinence in dogs.

TitleInvestigation of a novel treatment (urethral thermoplasty) for urinary incontinence in dogs.
Contact Person Audrey Cook, Dip ACVIM (Internal Medicine); Dip ABVP (Feline Practice)
Hospital Phone: 979-845-2351
Email: akcook@cvm.tamu.edu
Species Dogs
Inclusion Criteria and General Background Information Female dogs with urinary incontinence
Exclusion Criteria

Dogs with underlying urinary tract infection, stones, tumor or ectopic ureters not eligible for this trial.

Owner Commitments

Dogs will be screened for eligibility with a ultrasound examination of the urinary tract and a urine culture. Owners are responsible for the costs of this initial examination.

Urethral thermoplasty will be performed on a subsequent visit, and will require general anesthesia. Costs associated with thermoplasty are covered by the study.

Follow-up will last at least 6 months and will include phone calls and occasional visits to the hospital (covered by study)

Financial Incentives

There are no financial benefits for participation in this trial.

Study Information